Therapy for intrauterine growth restriction: Current options and future directions

Clinical Obstetrics and Gynecology

Volumn 40, Issue 4, 1997, Pages 824-842

  Pollack, Raphael N ^a   Yaffe, Haim ^a   Divon, Michael Y ^b  

^a BIKUR CHOLIM HOSPITAL   (Israel)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; DIPYRIDAMOLE; PYRIMETHAMINE; SOMATOMEDIN; SPIRAMYCIN; SULFADIAZINE;

BED REST; COUNSELING; DIET SUPPLEMENTATION; FETUS LUNG MATURATION; FETUS MONITORING; HUMAN; INTRAUTERINE GROWTH RETARDATION; NUTRITION; OXYGEN THERAPY; REVIEW; TREATMENT OUTCOME;

ADRENERGIC BETA-AGONISTS; ASPIRIN; ATRIAL NATRIURETIC FACTOR; BED REST; CYCLOOXYGENASE INHIBITORS; DIPYRIDAMOLE; FEMALE; FETAL GROWTH RETARDATION; HUMANS; MATERNAL WELFARE; NUTRITION PHYSIOLOGY; OXYGEN INHALATION THERAPY; PREGNANCY; SOMATOMEDINS; VASODILATOR AGENTS;

EID: 0031411509     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199712000-00017     Document Type: Review

References (90)

1. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985;12:82-90.
2. Battaglia FC. Intrauterine growth retardation. Am J Obstet Gynecol 1970;106:1103-1114.
3. Williams RL, Creasy RK, Cunningham GC, Hawes WE, Norris MA, Tashiro MS. Fetal growth and perinatal viability in California. Obstet Gynecol 1982;59:624-632.
4. Pollack RN, Divon MY. Intrauterine growth retardation: definition, classification, and etiology. Clin Obstet Gynecol 1992;35:99-107.
5. Khoury MJ, Erickson JD, Cordero JF, McCarthy BJ. Congenital malformations and intrauterine growth retardation: A population study. Pediatrics 1988;82:83-90.
6. Knox GE. Influence of infection on fetal growth and development. J Reprod Med 1978;21:352-358.
7. Nies BM, Lien JM, Grossman JH. Torch virus-induced fetal disease. In: Reece EA, Hobbins J, Mahoney M, Petrie RH, eds. Medicine of the Fetus and Mother. Philadelphia, PA: JB Lippincott Company, 1992:349-352.
8. Creasy RK, Barrett CT, de Swiet M, Kahanpaa KV, Rudolph AM. Experimental intrauterine growth retardation in the sheep. Am J Obstet Gynecol 1972;112:566-573.
9. Fox H. Pathology of the Placenta. Philadelphia, PA: WB Saunders, 1978:248.
10. Chazotte C, Girz B, Koenigsberg M, Cohen WR. Spontaneous infarction of placental chorioangioma and associated regression of hydrops fetalis. Am J Obstet Gynecol 1990;163:1180-1181.
11. Cunningham FG, MacDonald PC, Gant N, Leveno K, Gilstrap LC. Williams Obstetrics, 19th edition. Norwalk, CT: Appleton & Lange, 1993:881
12. Laurin J, Perrson PH. The effect of bedrest in hospital on fetal outcome in pregnancies complicated by intrauterine growth retardation. Acta Obstet Gynecol Scand 1987;66:407-411.
13. Stein Z, Susser M. The Dutch famine, 1944-1945 and the reproductive process: I. Effects on six indices at birth. Pediatr Res 1975;9:70-76.
14. Villar J, Khoury MJ, Finucane FF, et al. Differences in the epidemiology of prematurity and intrauterine growth retardation. Early Hum Dev 1986;14:307-320.
15. Viteri FE, Schumacher L, Silliman K. Maternal malnutrition and the fetus. Semin Perinatol 1989;13:236-249.
16. Caan B, Horgen DM, Margen S, et al. Benefits associated with WIC supplemental feeding during the interpregnancy interval. Am J Clin Nutr 1987;45:29-41.
17. Lee RV, Rodgers BD, Young C, Eddy E, Cardinal J. Total patenteral nutrition during pregnancy. Obstet Gynecol 1986;68:5637-5641.
18. Mesaki N, Kubo T, Iwasaki H. A study of the treatment for intrauterine growth retardation. Acta Obstet Gynecol Jpn 1980;32:879-885.
19. Beischer NA. Treatment of fetal growth retardation. Aust N Z J Obstet Gynecol 1978;18:28-33.
20. Wells JL, James DK, Luxton R, Pennock CA. Maternal leukocyte zinc deficiency at the start of the third trimester as a predictor of fetal growth retardation. Br Med J 1987;294:1054-1056.
21. Simmer K, Lort-Phillips L, James C, Thompson RPH. A double-blind trial of zinc supplementation in pregnancy. Eur J of Clin Nutr 1991;45:139-144.
22. Lunell N, Nylund L. Uteroplacental blood flow. Clin Obstet Gynecol 1992;35:108-118.
23. Divon MY, Hsu H. Maternal and fetal blood flow velocity waveforms in intrauterine growth retardation. Clin Obstet Gynecol 1992;35:156-171.
24. Leaf A, Weber P. Cardiovascular effects of n-3 fatty acids. N Engl J Med 1988;318:549-557.
25. Olsen S, Hansen HS, Sørensen TIA, et al. Intake of marine fat, rich in (n-3)-polyunsaturated fatty acids, may increase birth weight by prolonging gestation. Lancet 1986;2:367-369.
26. Andersen HJ, Andersen LF, Fuchs AR. Diet, pre-eclampsia, and intrauterine growth retardation. [Letter]. Lancet 1989;1:1146.
27. Sorensen JD, Olsen SF, Pedersen AK, Boris J, Secher NJ, FitzGerald GA. Effect of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production. Am J Obstet Gynecol 1993;168:915-922.
28. Cunningham FG, MacDonald PC, Gant N, Leveno K, Gilstrap LC. Williams Obstetrics, 19th edition. Norwalk, CT: Appleton & Lange, 1993:878.
29. Soothill PW, Nicolaides KH, Campbell S. Perinatal asphyxia, hyperlacticaemia, hypoglycemia, and erythroblastosis in growth- retarded fetuses. Br Med J 1987;294:1051-1053.
30. Nicolaides KH, Campbell S, Bradley RJ, Bilardo CM, Soothill PW, Gibb D. Maternal oxygen therapy for intrauterine growth retardation. Lancet 1987;1:942-945.
31. Battaglia C, Artini PG, D'Ambrogio G, Galli PA, Segre A, Genazzani AR. Maternal hyperoxygenation in the treatment of intrauterine growth retardation. Am J Obstet Gynecol 1993;167:430-435.
32. Harding JE, Owens JA, Robinson JS. Should we try to supplement the growth retarded fetus? A cautionary tale. Br J Obstet Gynecol 1992:99:707-710.
33. Wallenburg HCS, Rotmans N. Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. Am J Obstet Gynecol 1987;157:1230-1235.
34. Louden KA, Pipkin FB, Symonds EM, Tuohy P. O'Callaghan C, Heptinstall S, Fox S, Mitchell JRA. A randomized placebocontrolled study of the effect of low-dose aspirin on platelet reactivity and serum thromboxane B2 production in nonpregnant women, in normal pregnancy, and in gestational hypertension. Br J Obstet Gynecol 1992;99:371-376.
35. Sibai BM, Caritis SN, Thom E, et al. Prevention of pre-eclampsia with low-dose aspirin in healthy, nulliparous women. N Engl J Med 1993;329:1213-1218.
36. Trudinger BJ, Cook CM, Thompson RS, Giles WB, Connelly A. Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency. Am J Obstet Gynecol 1988;159:681-685.
37. Giles WB, Trudinger BJ, Baird PJ. Fetal umbilical artery flow velocity waveforms and placental resistance: Pathological correlation. Br J Obstet Gynecol 1985;92:31-38.
38. Uzan S, Beaufils M, Breart G, Bazin B, Capitant C, Paris J. Prevention of fetal growth retardation with low-dose aspirin: Findings of the EPREDA trial. Lancet 1991;337:1427-1431.
39. Italian Study of Aspirin in Pregnancy. Low-dose aspirin in the prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Lancet 1993;341:396-400.
40. CLASP Collaborative Group. CLASP: A randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343:619-629.
41. Lippert TH, DeGrandi PB, Roemer VM, Fridrich R. Hemodynamic changes in placenta, myometrium and heart after administration of the uterine relaxant ritodrine. Int J Clin Pharmacol Ther Toxicol 1980;18:15-20.
42. Cabero L, Cerqueira MJ, Del Solar J, Bellart J, Esteban-Altirriba J. Long-term hospitalization and beta-mimetic therapy in the treatment of intrauterine growth retardation of unknown etiology. J Perinat Med 1988;16:453-458.
43. Goetz KL. Physiology and pathophysiology of atrial peptides. Am J Physiol 1988;254:E1-E15.
44. Chemtob S, Potvin W, Verma DR. Selective increase in placental blood flow by atrial natriuretic peptide in hypertensive rats. Am J Obstet Gynecol 1989;160:477-479.
45. Reid DL, Goodfriend TL, Hollister MC, Phernetton TM, Rankin JHG. Effects of atrial natriuretic factor on maternal ovine vascular resistance. J Dev Physiol 1989;11:25-28.
46. Jansson TB. Low-dose infusion of atrial natriuretic peptide in the conscious guinea pig increases blood flow to the placenta in growth-retarded fetuses. Am J Obstet Gynecol 1992;166:213-218.
47. Kingdom JCP, McQueen J, Connell JMC, Whittle MJ. Maternal and fetal atrial natriuretic peptide levels at delivery from normal and growth retarded pregnancies. Br J Obstet Gynecol 1992;99:845-849.
48. McQueen J, Kingdom JCP, Jardine AG, Connell JMC, Whittle MJ. Vascular angiotensin II and atrial natriuretic peptide receptors in normal and growth-retarded human placentae. J Endocrinol 1990b;126:341-347.
49. Langford KS, Miell JP. The insulin-like growth factor-1/binding protein axis: Physiology, pathophysiology, and therapeutic manipulation. Eur J Clin Invest 1993;23:503-516.
50. Bernstein IM, DeSouza MM, Copeland KC. Insulin-like growth factor-1 in substrate de- prived growth retarded fetal rats. Pediatr Res 1991;30:154-157.
51. Muaku SM, Beauloye V, Thissen JP, Underwood LE, Fossion C, Gerard G, Ketelslegers JM, Matter D. Long-term effects of gestational protein malnutrition on postnatal growth, insulin-like growth factor (IGF-1), and IGF-binding protein in rat progeny. Pediatr Res 1996;39:649-655.
52. Unterman TG, Simmons RA, Glick RP, Ogata ES. Circulating levels of insulin, insulin-like growth factor-1 (IGF-1), IGF-2, and IGF-binding proteins in the small for gestational age fetal rat. Endocrinology 1993;132:327-336.
53. Kind KL, Owens JA, Robinson JS, et al. Effect of restriction of placental growth on expression of IGFs in fetal sheep: Relationship of fetal growth, circulating IGFs, and binding proteins. J Endocrinol 1995;146:23-34.
54. Woodall SM, Brier BH, Johnston BM, Gluckman PD. A model of intrauterine growth retardation caused by chronic maternal undernutrition in the rat: Effects on the somatotrophic axis and postnatal growth. J Endocrinol 1996;150:231-242.
55. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990;345:78-80.
56. Liu JP, Baker J, Perkins A, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and Type 1 IGF receptor (IGF1r). Cell 1993;75:59-72.
57. Powell-Braxton L, Hollingshead P, Warburton C, et al. IGF-1 is required for normal embryonic growth in mice. Genes Dev 7:2609-2617.
58. Han VKM, Bassett N, Wallon J, Challis JRG. The expression of insulin-like growth factor (IGF) and IGF-Binding protein (IGFBP) genes in the human placenta and membranes: Evidence for IGF - IGFBP interactions at the feto-matemal interface. J Clin Endocrinol Metab 1996;81:2680-2693.
59. Hills FA, English J, Chard T. Circulating levels of IGF-1 and GF-binding protein-1 throughout pregnancy: Relation to birth weight and maternal weight. J Endocrinol 1996;148:303-309.
60. Nieto-Diaz A, Villar J, Matorras-Weinig R, Valenzuela-Ruiz P. Intrauterine growth retardation at term: Association between anthropomorphic and endocrine parameters. Acta Obstet Gynecol Scand 1995;75:127-131.
61. Verhaeghe J, Van Bree R, Van Herck E, Laureys J, Bouillon R, Van Assche A. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: Correlations with birth weight. Am J Obstet Gynecol 1993;169:89-97.
62. Giudice LC, de Zegher F, Gargofsky SE, et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995;80:1548-1555.
63. Lassarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M. Serum insulin-like growth factor and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 1991;29:219-225.
64. Langford K, Blum W, Nicolaides K, Jones J, McGregor A, Miell J. The pathophysiology of the insulin-like growth factor axis in fetal growth failure: A basis for programming by undeniutrition. Eur J Clin Invest 1994;24:851-856.
65. Leger J, Noel M, Limal JM, Czernichow P. Growth factors and intrauterine growth retardation. II. Serum growth hormone, Insulin-like growth factor(IGF), and IGF-binding protein-3 levels in children with intrauterine growth retardation compared with normal control subjects: Prospective study from birth to two years of age. Pediatr Res 1996;40:101-107.
66. Woods K.K., Camocho-Hubner C, Savage MO, Clark AJL. Intrauterine growth retardation and postnatal growth failure associated with the deletion of the insulin-like growth factor-1 gene. N Engl J Med 1996;335:1363-1367.
67. Gluckman PD, Morel PCH, Ambler GR, Breier BH, Blair HT, McCutcheon SN. Elevating maternal insulin-like growth factor- 1 in mice and rats alters the pattern of fetal growth by removing maternal constraint. J Endocrinol 1992;134:R1-R3.
68. Liu L, Harding JE, Evans PC, Gluckman PD. Maternal insulin-like growth factor-1 infusion alters fetoplacental carbohydrate and protein metabolism in pregnant sheep. Endocrinol 1994;135:895-890.
69. Pitkin RM, Reynolds WA. Fetal ingestion and metabolism of amniotic fluid proteins. Am J Obstet Gynecol 1976;123:356-363.
70. Charlton V, Rudolph AM. Digestion and absorption of carbohydrates by the fetal lamb in utero. Pediatr Res 1979;13:1018-1023.
71. Gitlin D, Kumate J, Morales C, Noriega L, Arevalo N. The turnover of amniotic fluid protein in the human conceptus. Am J Obstet Gynecol 1972;113:632-645.
72. Lilley AW. Disorders of amniotic fluid. In: Assali NS, ed. Pathophysiology of Gestation, Vol.2. New York, NY: Academic Press, 1972:157-206.
73. Harding JE, Charlton V. Experimental nutritional supplementation for intrauterine growth retardation. In: Harrison MR, Golbus M, Filey R, eds. The Unborn Patient, 2nd edition. Philadelphia, PA: Saunders, 1991:598-613.
74. Mulvihill SJ, Stone MM, Debas HT, Fonkalsrud EW. The role of amniotic fluid in fetal nutrition. J Pediatr Surg 1985;20(6):668-672.
75. Mulvihill SJ, Albert A, Synn A, Fonkalsrud. In utero supplemental fetal feedings in an animal model: Effects on fetal growth and development. Surgery 1985;98:500-505.
76. Flake AW, Villa RL, Adzick S, Harrison MR. Transamniotic fetal feeding III. A model of intrauterine growth retardation using the relationship of "natural runting" to uterine position. J Pediatr Surg 1987;22:816-819.
77. Flake AW, Villa-Troyer RL, Adzick NS, Harrison MR. Transamniotic fetal feeding. II. The effect of nutrient infusion on fetal growth retardation. J Pediatr Surg 1986;21:481-484.
78. Buchmiller TL, Kim CS, Chopourian L, Fonkalsrud EW. Transamniotic fetal feeding: Enhancement of growth in a rabbit model of intrauterine growth retardation. Surgery 1994;116:36-41.
79. Buchmiller TL, Shaw KS, Chopourian HL, et al. Effect of transamniotic administration of epidermal growth factor on fetal rabbit small intestinal nutrient transport and disaccharidase development. J Pediatr Surg 1993;8:1239-1244.
80. Charlton V, Johengen M. Effects of intrauterine nutritional supplementation on fetal growth retardation. Biol Neonate 1985;48:125-142.
81. Charlton V, Johengen M. Fetal intravenous nutritional supplementation ameliorates the development of embolization-induced growth retardation in sheep. Pediatr Res 1987;22:55-61.
82. Shimonovitz S, Yagel S, Zacut D, et al. Intermittent abdominal decompression: An option for the prevention of intrauterine growth retardation. Br J Obstet Gynecol 1992;99:693-695.
83. Hofmeyr GF, Metrikin DC, Williamson I. Abdominal decompression: new data from a previous study. Br J Obstet Gynecol 1990;97:547-548.
84. Heyns OS, Samson NS, Graham JAC. Influence of abdominal decompression on intra- amniotic pressure and fetal oxygenation. Lancet 1962;i:282-292.
85. Hofmeyr GJ, Abdominal decompression in pregnancy. In: Chalmers I, Enkin M, Keirse MJNC, eds. Effective Care in Pregnancy and Childbirth. New York, NY: Oxford University Press, 1989:647-652.
86. Liggins JC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for the prevention of respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-525.
87. Crowley P, Chalmers I, Keirse MJNC. The effects of corticosteroid administration before preterm delivery: An overview of the evidence from controlled trials. Br J Obstet Gynecol 1990;97:11-25.
88. NIH Consensus statement. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Publication No.95-3784. Nov 1994:3-14.
89. Perelman RH, Farrell PM, Engle MJ, Kemnitz JW. Developmental aspects of lung lipids. Ann Rev Physiol 1985;47:803-822.
90. Owen J, Baker SL, Hauth JC, Goldenberg RL, Davis RO, Copper RL. Is indicated or spontaneous preterm delivery more advantageous to the fetus. Am J Obstet Gynecol 1990;163:868-872.